Progressive Care Inc (RXMD)

[MrMike241]

$RXMD will uplist between $0.10 and $0.25 PPS:
IMO, but the PPS needs to get there first.

SEC Form 10-12G filed 2/9/2022, registering RXMD securities with the SEC, and disclosing more information than most people will read, including me. It includes employment agreements, stock and option incentive plans, financials, etc. That is significant because it shows that everything expected is happening on schedule.

The uplist target is $5 PPS post-split, and it will NOT happen below $0.05 PPS pre-split:

The company’s goal is to repay the debt from the capital raised at the uplist offering.

We have negotiated a discount to the note of $180,000 if we uplist by February 16. If not then that discount becomes $80,000 instead of $180,000.

no more conversions, no more dilution, no more T trades.

I’m not interested in anything above a 100:1. Hope with our joint efforts and Chicago being out of our way, we can get this ratio to 50:1 or less.

The quiet period is in force until S-1 is effective.

-- Armen Karapetyan,  Telegram,  1/24/2022, answering questions about this PR: Progressive Care Successfully Negotiates Settlement Agreement

* At $0.05 PPS pre-split the marketcap is feasible with current information, but the OS would be too low to support active trading on NASDAQ.

* At $0.10 PPS pre-split the marketcap is feasible with current information, and the OS would be tight, but probably enough to support active trading on NASDAQ.

* At $0.25 PPS pre-split and higher, the marketcap probably needs more material news to justify the valuation. IMO, $0.25 is the sweet spot for OS and Unissued AS on NASDAQ (AS will be 100M).



The uplist offering shares will certainly sell, perhaps at $5, with a warrant to purchase another share at the same price. The Warrants are like risk free options for those that believe the company is growing. My guess is that Benchmark has already secured buyers for all of the shares, but that IS a guess.

Upon uplist RXMD will be convertible debt free, only the mortgage and leases will remain. And RXMD will have the funding to implement their technology expansion plan; ClearMetrX. That's what all of the news is about

Insiders believe. The CEO just bought 1.5M, and he's holding over 8M. The CFO just bought 1M. And the founder already gave up his consulting fee and agreed to exchange his super voting preferred shares for common shares. He's already the largest shareholder, and after the transaction, he'll have 67M common shares pre-split. His ability to control the vote will be removed. Why would he do this? It must be that he knows his common shares will have great value. Money.

I'm loaded and I'm following the Money.

Good Luck to Us!

Go RXMD!

investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843

ProgressiveCareUS.com

PharmCoRx.com

ClearMetrX.com

facebook.com/ProgressiveCareUS

facebook.com/PharmCoRx

facebook.com/ClearMetrX

twitter.com/ProgressCareUS

twitter.com/PharmCoRx

twitter.com/ClearMetrX

otcmarkets.com/stock/RXMD/news

otcmarkets.com/stock/RXMD/disclosure

otcmarkets.com/stock/RXMD/security

investorshub.advfn.com/Progressive-Care-Inc-RXMD-19843